Matthew M. Loar
Corporate Officer/Principal en The American Institute of Certified Public Accountants .
Perfil
Matthew M.
Loar currently works at The American Institute of Certified Public Accountants, as Member.
Mr. Loar also formerly worked at Neurobiological Technologies, Inc., as Director, Chief Executive & Financial Officer from 2012 to 2014, Transcept Pharma, Inc., as Independent Director, Oncotelic Therapeutics, Inc., as Chief Financial Officer & Secretary in 2019, Genelabs Technologies, Inc., as Chief Financial Officer from 1995 to 2006, KineMed, Inc., as Chief Financial Officer from 2014 to 2015, Virolab, Inc., as Chief Financial Officer from 2011 to 2012, and Osteologix Holdings Plc, as Chief Financial Officer & Secretary from 2006 to 2008.
Mr. Loar received his undergraduate degree from the University of California, Berkeley.
Cargos activos de Matthew M. Loar
| Empresas | Cargo | Inicio |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Matthew M. Loar.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Director Financiero/CFO | 30/06/2019 |
| KINEMED INC | Director Financiero/CFO | 01/07/2015 |
Virolab, Inc.
 Virolab, Inc. Financial ConglomeratesFinance Virolab, Inc. operated as a development stage company which engaged in the development and commercialization of products to improve human healthcare. It developed investigational therapeutic vaccine for the human papillomavirus and HPV-related cancers and a diagnostic blood test for HPV. The company was founded on May 4, 2010 and was headquartered in Foster City, CA. | Director Financiero/CFO | 01/08/2012 |
| OSTEOLOGIX HOLDINGS PLC | Director Financiero/CFO | 01/04/2008 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Director Financiero/CFO | 01/09/2006 |
Formación de Matthew M. Loar.
| University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NEUROBIOLOGICAL TECHNOLOGIES, INC. | Health Technology |
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Virolab, Inc.
Virolab, Inc. Financial ConglomeratesFinance Virolab, Inc. operated as a development stage company which engaged in the development and commercialization of products to improve human healthcare. It developed investigational therapeutic vaccine for the human papillomavirus and HPV-related cancers and a diagnostic blood test for HPV. The company was founded on May 4, 2010 and was headquartered in Foster City, CA. | Finance |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services KineMed, Inc. develops and commercializes biomarker platform technology. It provides dynamic proteomics platform, a functionally interpretable systems biology platform. The company was founded by David M. Fineman and Marc K. Hellerstein in February 2001 and is headquartered in Emeryville, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Matthew M. Loar
